Furthermore, some mimics such as CD82 ECL1 mimic peptide (He, Ma, Wang, Luan, Li, Huang et al., 2021) and CD9-binding peptide (RSHRLRLH) (Suwatthanarak et al., 2021), may also provide an effective anti-metastasis approach to integrated cancer therapy. The gene discussed is CD9; the disease is cancer.